Rob Pace New CEO of Osseus

Rob Pace is the new CEO of Dallas, Texas-based Osseus Fusion Systems, LLC. Pace has over 26 years of experience as a sales and operations executive; 18 of those years were with companies he founded or co-founded.

Before co-founding Osseus in 2012, Pace co-founded the Socius Surgical Group, which distributed spinal implant and biologics nationwide but had a focus on the southern U.S. and had 11 direct representatives and 16 distributor affiliates. Before merging with Osseus in early 2014, Socius’ yearly gross sales topped $7.6 million.

Pace has a long history of business success. According to the company, “In 2000, Rob founded and served as the Managing Partner of East Paces, LP, a real estate investment firm. East Paces’ investments consisted of land purchased for development, multi-family housing, commercial property, and medical office buildings. The company also developed a program for the largest credit union in Texas, which provided its members access to housing and commercial development through low-cost lending programs. During that period, total real estate sales were $88.5 million and the EBITA exceeded 22%.”

“In 1996, Rob entered the medical sector, by co-founding and serving as President of NSYNC Consulting, an employee benefit and provider contract consulting firm. During his tenure, he worked on behalf of employers, medical practices, and surgical facilities to successfully negotiate a variety of managed care, capitated, and fee-for-service contracts with insurance carriers. He sold his interest in the company in 2001, after building a client list of over 60 companies and medical practices which generated yearly sales in excess of $19 million.”

Pace talked about his management style to OTW, “The key component in building a great company is finding members that are dedicated to the company’s objectives and that take tremendous pride in how they perform on a daily basis. As a new technology spine implant manufacturer, Osseus is committed to building a team that truly believes—and is invested—in making people’s lives better.”

“It’s an exciting time for Osseus. Between the close of 2018 and the close of 2019, we doubled our product portfolio, which includes several cutting-edge technology products. As an organically funded, privately held company, the ability to compete with a full portfolio is critical. That goal has now been accomplished.”